Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis/Supply Chain Analysis
6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT
6.1. Overview
6.2. Instruments
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.1. Blood Processing Devices
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.1.1. Centrifuges
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.1.2. Blood Cell Processors
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.2. Blood Transfusion Devices
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.2.1. Apheresis Machines
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.2.2. Plasma & Plasma Component Separators
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.2.3. Cell Salvage Systems
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.2.4. Others
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.3. Blood Culture Screening Devices
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.3.1. Automated Blood Culture Systems
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.3.2. Supporting Laboratory Equipment
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.4. Diagnostic & Testing Instruments
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.4.1. PCR Instruments
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.4.2. Hematology Analyzers
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.4.3. NGS Platforms
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.4.4. Blood Grouping Analyzers
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.5. Blood Storage Devices
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.5.1. Medical Refrigerators
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.2.5.2. Medical Freezers
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3. Accessories
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.1. Syringes & Needles
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.2. Vials & Tubes
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.3. Blood Bags
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.4. Others
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.4. Reagents and Kits
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.4.1. Culture Media
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.4.2. Reagents
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.4.3. Kits
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.4.4. Others
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.5. Software
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT
7.1. Overview
7.2. Whole Blood
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
7.3. Plasma
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER
8.1. Overview
8.2. Blood Banks
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
8.3. Hospitals
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
8.4. Diagnostic Clinics and & Pathology Labs
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1.1. Overview
10.1.2. Competitive Analysis
10.1.3. Market Share Analysis
10.1.4. Major Growth Strategy in the global patient blood management market
10.1.5. Competitive Benchmarking
10.1.6. Leading Player in terms of Number of Developments in the global patient blood management market
10.1.7. Key Developments & Growth Strategies
10.1.7.1. Product Launch
10.1.7.2. Merger & Acquisition
10.1.7.3. Joint Ventures
10.1.8. Major Players Financial Matrix
10.1.8.1. Sales & Operating Income 2019
10.1.8.2. Major Players R&D Expenditure 2019
11. COMPANY PROFILES
11.1. Biomérieux SA
11.1.1. Company Overview
11.1.2. Product Type Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Product Type Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Fresenius Se & Co. KGaA
11.3.1. Company Overview
11.3.2. Product Type Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. B. Braun Melsungen AG
11.4.1. Company Overview
11.4.2. Product Type Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Abbott Laboratories
11.5.1. Company Overview
11.5.2. Product Type Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Type Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Hitachi, Ltd.
11.7.1. Company Overview
11.7.2. Product Type Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Terumo Corporation
11.8.1. Company Overview
11.8.2. Product Type Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Grifols, S.A
11.9.1. Company Overview
11.9.2. Product Type Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Immucor, Inc.
11.10.1. Company Overview
11.10.2. Product Type Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SYNOPSIS, 2019–2027
TABLE 2 GLOBAL PATIENT BLOOD MANAGEMENT MARKET ESTIMATES & FORECAST, 2019–2027 (USD MILLION)
TABLE 3 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 4 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 5 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 6 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 7 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 8 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 10 US: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 11 US: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 12 US: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 13 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 14 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 15 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 16 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 17 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 18 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 19 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 20 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 21 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)  
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PATIENT BLOOD MANAGEMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PATIENT BLOOD MANAGEMENT MARKET
FIGURE 4 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY PRODUCT, 2019 (%)
FIGURE 5 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COMPONENT, 2019 (%)
FIGURE 6 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY END USER, 2019 (%)
FIGURE 7 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY REGION, 2019 (%)
FIGURE 7 AMERICAS: PATIENT BLOOD MANAGEMENT MARKET SHARE BY REGION, 2019 (%)
FIGURE 8 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 9 EUROPE: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY REGION, 2019 (%)
FIGURE 10 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 11 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 12 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 13 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2019 (%)
FIGURE 14 BIOMÉRIEUX SA: KEY FINANCIALS
FIGURE 15 BIOMÉRIEUX SA: SEGMENTAL REVENUE
FIGURE 16 BIOMÉRIEUX SA: REGIONAL REVENUE
FIGURE 17 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS
FIGURE 18 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUE
FIGURE 19 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE
FIGURE 20 FRESENIUS SE & CO. KGAA: KEY FINANCIALS
FIGURE 21 FRESENIUS SE & CO. KGAA: SEGMENTAL REVENUE
FIGURE 22 FRESENIUS SE & CO. KGAA: REGIONAL REVENUE
FIGURE 23 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 24 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 25 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE
FIGURE 26 ABBOTT LABORATORIES: KEY FINANCIALS
FIGURE 27 ABBOTT LABORATORIES: SEGMENTAL REVENUE
FIGURE 28 ABBOTT LABORATORIESREGIONAL REVENUE
FIGURE 29 DANAHER CORPORATION: KEY FINANCIALS
FIGURE 30 DANAHER CORPORATION: SEGMENTAL REVENUE
FIGURE 31 DANAHER CORPORATION: REGIONAL REVENUE
FIGURE 32 HITACHI, LTD: KEY FINANCIALS
FIGURE 33 HITACHI, LTD.: SEGMENTAL REVENUE
FIGURE 34 HITACHI, LTD: REGIONAL REVENUE
FIGURE 35 TERUMO CORPORATION.: KEY FINANCIALS
FIGURE 36 TERUMO CORPORATION.: SEGMENTAL REVENUE
FIGURE 37 TERUMO CORPORATION.: REGIONAL REVENUE
FIGURE 38 GRIFOLS, S.A: KEY FINANCIALS
FIGURE 39 GRIFOLS, S.A: SEGMENTAL REVENUE
FIGURE 40 GRIFOLS, S.A: REGIONAL REVENUE
FIGURE 41 IMMUCOR, INC.: KEY FINANCIALS
FIGURE 42 IMMUCOR, INC.: SEGMENTAL REVENUE
FIGURE 43 IMMUCOR, INC.: REGIONAL REVENUE